Centre Hospitalier Régional Universitaire de Besançon

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma	Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm	Active, not recruiting	Phase 3	2026-07-06		NCT05948475
Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life	Tumor With Bone Metastasis	Active, not recruiting	Not applicable	2024-12-27		NCT02839291

Clinical trials